HRAS and cardiac hypertrophy: The normal isoform of H-Ras stimulates a physiological form of cardiac hypertrophy, through the ERK pathway, while its oncogenic mutant H-Ras-Val12 (constitutive active) stimulates pathological hypertrophy through the Calcineurine/NFAT pathway [24, 25].